Institute of Medical Science, University of Toronto, Toronto, Canada.
Department of Medicine, University of Toronto, Toronto, Canada.
Epidemics. 2022 Sep;40:100608. doi: 10.1016/j.epidem.2022.100608. Epub 2022 Jul 8.
Transmission models provide complementary evidence to clinical trials about the potential population-level incidence reduction attributable to ART (ART prevention impact). Different modelling assumptions about risk heterogeneity may influence projected ART prevention impacts. We sought to review representations of risk heterogeneity in compartmental HIV transmission models applied to project ART prevention impacts in Sub-Saharan Africa.
We systematically reviewed studies published before January 2020 that used non-linear compartmental models of sexual HIV transmission to simulate ART prevention impacts in Sub-Saharan Africa. We summarized data on model structure/assumptions (factors) related to risk and intervention heterogeneity, and explored multivariate ecological associations of ART prevention impacts with modelled factors.
Of 1384 search hits, 94 studies were included. 64 studies considered sexual activity stratification and 39 modelled at least one key population. 21 studies modelled faster/slower ART cascade transitions (HIV diagnosis, ART initiation, or cessation) by risk group, including 8 with faster and 4 with slower cascade transitions among key populations versus the wider population. In ecological analysis of 125 scenarios from 40 studies (subset without combination intervention), scenarios with risk heterogeneity that included turnover of higher risk groups were associated with smaller ART prevention benefits. Modelled differences in ART cascade across risk groups also influenced the projected ART benefits, including: ART prioritized to key populations was associated with larger ART prevention benefits. Of note, zero of these 125 scenarios considered lower ART coverage among key populations.
Among compartmental transmission models applied to project ART prevention impacts in Sub-Saharan Africa, representations of risk heterogeneity and projected impacts varied considerably. Inclusion/exclusion of risk heterogeneity with turnover, and intervention heterogeneity across risk groups could influence the projected impacts of ART scale-up. These findings highlight a need to capture risk heterogeneity with turnover and cascade heterogeneity when projecting ART prevention impacts.
传播模型为临床试验提供了关于抗逆转录病毒疗法(ART)对人群发病率降低的潜在影响(ART 预防效果)的补充证据。对风险异质性的不同建模假设可能会影响预期的 ART 预防效果。我们旨在综述在撒哈拉以南非洲应用于预测 ART 预防效果的性传播 HIV 传播的房室模型中对风险异质性的表示。
我们系统地综述了 2020 年 1 月之前发表的使用非线性房室 HIV 性传播模型来模拟撒哈拉以南非洲地区 ART 预防效果的研究。我们总结了有关模型结构/假设(因素)的资料,这些因素与风险和干预的异质性有关,并探索了 ART 预防效果与模型因素之间的多变量生态关联。
在 1384 次搜索中,有 94 项研究被纳入。64 项研究考虑了性行为分层,39 项研究对至少一个关键人群进行了建模。21 项研究对风险组的 ART 级联更快/更慢的转变(HIV 诊断、开始或停止 ART)进行了建模,包括 8 项针对关键人群,4 项针对关键人群与更广泛人群相比更快的级联转变。在对来自 40 项研究的 125 个方案(不包括联合干预的子集中)的生态分析中,包括较高风险组更替的风险异质性方案与较小的 ART 预防效益相关。跨风险组的 ART 级联差异也影响了预测的 ART 效益,包括:针对关键人群的 ART 优先考虑与更大的 ART 预防效益相关。值得注意的是,在这 125 个方案中,没有一个考虑到关键人群中较低的 ART 覆盖率。
在应用于撒哈拉以南非洲地区预测 ART 预防效果的房室传播模型中,风险异质性的表示及其预测效果差异很大。包括/排除具有更替的风险异质性和跨风险组的干预异质性可能会影响 ART 扩大规模的预测效果。这些结果突出表明,在预测 ART 预防效果时,需要捕获具有更替和级联异质性的风险异质性。